Ori biotech: Manufacturing Brighter Futures— Introducing the Next Generation of CGT Manufacturing Technology
Wednesday, May 29, 2024 12:00 PM - 01:00 PM
Plenary Hall
Corporate Session
Chair
Be the first to hear the initial results of Ori’s LightSpeed Early Access Program Partnership with CTMC— presented by CTMC CEO Jason Bock. During this session, we will reveal the details on how Ori’s full-stack manufacturing platform automates, digitizes and standardizes CGT manufacturing to deliver exceptional biological results and enable therapy developers to seamlessly transition from pre-clinical process discovery to commercial scale.
Session Objectives:
To provide a detailed understanding of how Ori’s hardware, software and analytical tools are delivering industry-leading biological results which will ultimately enable manufacturing of cell and gene therapies at scale.
- Jason C. Foster, CEO, Oribiotech, UK, USA
- Jason Bock, Co-Founder & CEO, CTMC, USA
Be the first to hear the initial results of Ori’s LightSpeed Early Access Program Partnership with CTMC— presented by CTMC CEO Jason Bock. During this session, we will reveal the details on how Ori’s full-stack manufacturing platform automates, digitizes and standardizes CGT manufacturing to deliver exceptional biological results and enable therapy developers to seamlessly transition from pre-clinical process discovery to commercial scale.
Session Objectives:
To provide a detailed understanding of how Ori’s hardware, software and analytical tools are delivering industry-leading biological results which will ultimately enable manufacturing of cell and gene therapies at scale.
SPONSORED BY:
